1781 Stock Overview
Manufactures and sells products for cardiovascular disease, in-vitro diagnostics, and respiratory care worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Health & Life Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$17.40 |
| 52 Week High | NT$23.55 |
| 52 Week Low | NT$14.60 |
| Beta | 0.91 |
| 1 Month Change | -3.06% |
| 3 Month Change | 6.75% |
| 1 Year Change | 14.47% |
| 3 Year Change | 14.47% |
| 5 Year Change | 41.46% |
| Change since IPO | -84.71% |
Recent News & Updates
Shareholder Returns
| 1781 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | 14.5% | -6.4% | 28.6% |
Return vs Industry: 1781 exceeded the TW Medical Equipment industry which returned -6.4% over the past year.
Return vs Market: 1781 underperformed the TW Market which returned 28.6% over the past year.
Price Volatility
| 1781 volatility | |
|---|---|
| 1781 Average Weekly Movement | 5.9% |
| Medical Equipment Industry Average Movement | 3.8% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 1781 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 1781's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | n/a | n/a | www.healthandlife.com.tw |
Health & Life Co., Ltd. manufactures and sells products for cardiovascular disease, in-vitro diagnostics, and respiratory care worldwide. It offers vibrating mesh nebulizers, blood pressure monitor products, IR thermometers, and hearing aid devices. The company was founded in 1996 and is based in New Taipei City, Taiwan.
Health & Life Co., Ltd. Fundamentals Summary
| 1781 fundamental statistics | |
|---|---|
| Market cap | NT$824.89m |
| Earnings (TTM) | -NT$9.93m |
| Revenue (TTM) | NT$661.18m |
1.2x
P/S Ratio-83.1x
P/E RatioIs 1781 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1781 income statement (TTM) | |
|---|---|
| Revenue | NT$661.18m |
| Cost of Revenue | NT$542.56m |
| Gross Profit | NT$118.62m |
| Other Expenses | NT$128.55m |
| Earnings | -NT$9.93m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.21 |
| Gross Margin | 17.94% |
| Net Profit Margin | -1.50% |
| Debt/Equity Ratio | 52.6% |
How did 1781 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 18:52 |
| End of Day Share Price | 2025/01/22 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Health & Life Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yijun Chen | SinoPac Securities Investment Service |